REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dan Quimica C.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Dan Quimica C.A. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Dan Quimica C.A. is an enterprise in Ecuador, with the main office in Montecristi. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on July 14, 1980. It currently has a total number of 9 (2023) employees. In 2023, the company reported a net sales revenue increase of 109.77%. During that time, Dan Quimica C.A.’s total assets decreased by 21.76%. In, 2023, the company’s net profit margin decreased by 0.26%.

Headquarters
Km 11 1/2 Via Manta-portoviejo
Montecristi; Manabi;

Contact Details: Purchase the Dan Quimica C.A. report to view the information.

Website: http://www.danquimica.com

Basic Information
Total Employees:
Purchase the Dan Quimica C.A. report to view the information.
Outstanding Shares:
Purchase the Dan Quimica C.A. report to view the information.
Registered Capital:
Purchase the Dan Quimica C.A. report to view the information.
Incorporation Date:
July 14, 1980
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
17.53%
Purchase this report to view the information.
17.36%
Purchase this report to view the information.
11.94%
Purchase this report to view the information.
11.94%
Purchase this report to view the information.
11.94%
Subsidiaries
Clinica Manta C.A.
3.22%
Company Performance
Financial values in the chart are available after Dan Quimica C.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
109.77%▲
Total operating revenue
-32.28%▼
Operating profit (EBIT)
-96.83%▼
EBITDA
-96.69%▼
Net Profit (Loss) for the Period
-79.68%▼
Total assets
-21.76%▼
Total equity
-38.49%▼
Operating Profit Margin (ROS)
-237.47%▼
Net Profit Margin
-0.26%▼
Return on Equity (ROE)
-0.1%▼
Debt to Equity Ratio
-1.02%▼
Quick Ratio
-0.22%▼
Cash Ratio
-0.04%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo